Results

Total Results: 68 records

Showing results for "buprenorphine".

1. CHIPRA 218: Section 1, Tables 1 to 5 (pdf file)
   www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-218-section-1-tables-1-5.pdf
   May 01, 2019 - Quaternary Ammonium Compounds Partial opioid Agonist [EPC], Partial opioid Agonists [MoA] • Buprenorphine … • Buprenorphine Hydrochloride Partial opioid Agonist [EPC], Partial opioid Agonists [MoA], opioid … Antagonist [EPC], opioid Antagonists [MoA] • Buprenorphine Hydrochloride; Naloxone Hydrochloride

2. Buprenorphine Education Improves Rural Practice Adoption for Opioid Use Disorder Treatment | Agency for Healthcare Research and Quality
   www.ahrq.gov/news/newsletters/e-newsletter/798.html
   February 01, 2022 - Buprenorphine Education Improves Rural Practice Adoption for Opioid Use Disorder Treatment Issue … Today's Headlines: Buprenorphine Education Improves Rural Practice Adoption for Opioid Use Disorder … guidelines support the use of buprenorphine as a treatment for opioid use disorder (OUD), adoption has … While under 20 percent of participating practices reported utilizing buprenorphine treatment prior to … IT MATTTRs appears to be an effective resource for implementing buprenorphine treatment for OUD in primary

3. Making Healthcare Safer Practices: 10. Harms Due to Opioids (pdf file)
   www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/opioids-1.pdf
   March 01, 2020 - Buprenorphine. https://www.samhsa.gov/medication-assisted-treatment/treatment/buprenorphine. … standard outpatient (OP) buprenorphine treatment for African Americans. … Buprenorphine-naloxone maintenance following release from jail. … Home buprenorphine/naloxone induction in primary care. … (35.7%) completed six- month buprenorphine treatment.

4. CHIPRA 218: Section 2, Technical Specifications (pdf file)
   www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-218-section-2-tech-specs.pdf
   May 01, 2019 - Agonist [EPC], Partial opioid Agonists [MoA], opioid Antagonist [EPC], opioid Antagonists [MoA] • Buprenorphine … • Buprenorphine Hydrochloride • Buprenorphine Hydrochloride; Naloxone Hydrochloride

5. Analysis Concludes Medicare Drug Plans Should Eliminate Barriers to Opioid Use Disorder Treatment | Agency for Healthcare Research and Quality
   www.ahrq.gov/news/newsletters/e-newsletter/653.html
   February 01, 2019 - Buprenorphine, which may cause less dependence and fewer withdrawal symptoms than other opioids, is often … AHRQ-funded researchers who analyzed drug formularies found that Part D coverage for buprenorphine was … In 2018,generic buprenorphine tablets were covered by all plans. … And about three-fourths of plans covered brand-name and generic versions of buprenorphine-naloxone, which … For example, prescriptions for generic buprenorphine tablets, despite having the lowest cost (about $80

6. Online Training Enables Primary Care Providers in Rural New Mexico to Prescribe Medication for Opioid Use Disorders | Agency for Healthcare Research and Quality
   www.ahrq.gov/news/newsroom/case-studies/202304.html
   October 01, 2023 - the MOUD ECHO program to learn about opioid use disorder, treatment using medications (particularly buprenorphine … Participants meet key benchmarks along the way during their training, including getting a license to prescribe buprenorphine … Gallup Indian Medical Center, said, “The MOUD ECHO program showed me how safe and truly lifesaving buprenorphine … We now collaborate extensively with our Emergency Department providers, who are excited to prescribe buprenorphine

7. Emergency Visits for Opioid Use Rose White Treatment for Illicit Drug Use Remained Unchanged (pdf file)
   www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/qdr-data-spotlight-opioids-edvisits-tx.pdf
   August 11, 2021 - ◆ Third, EDs should expand capacity for prescribing buprenorphine. … Buprenorphine is a safe, effective OUD treatment that any licensed clinician who has received a Key … The medications (buprenorphine, buprenorphine/naloxone and/ or naltrexone) are available for treatment … Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized … Barriers and facilitators to clinician readiness to provide emergency department-initiated buprenorphine

8. Agency for Healthcare Research and Quality
   www.ahrq.gov/research/findings/studies/index.html?page=52
   January 01, 2024 - , difficulty hiring buprenorphine providers, managing tension between harm reduction and traditional … Implementation facilitators included receiving technical assistance from DOHMH, having designated buprenorphine … coordinator and ensure regular training on buprenorphine for frontline staff, and (3) buprenorphine … providers should be selected or supported to use a harm reduction approach to buprenorphine treatment … Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation

9. AHRQ Topic Brief Supports Primary Care Treatment of Opioid Use Disorder | Agency for Healthcare Research and Quality
   www.ahrq.gov/news/oud-brief.html
   October 01, 2023 - barriers common to conventional OUD treatment and prioritizes “medication first” through prescribing buprenorphine

10. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=107
    January 01, 2024 - The treatment analyzed was use of buprenorphine. … Only 1 in 10 eligible individuals with OUD initiated buprenorphine within 365 days of diagnosis with … 2850 individuals (6.3%) initiating buprenorphine within 14 days of diagnosis. … Of the 4600 individuals who received buprenorphine, half were maintained in care with 180 days or more … Quality of buprenorphine care for insured adults with opioid use disorder.

11. Recent Data Analyses | Agency for Healthcare Research and Quality
    www.ahrq.gov/opioids/data/analyses.html
    November 01, 2022 - prepublication, 24 December 2019. doi: 10.1016/j.addbeh.2019.106268 Price elasticity of demand for buprenorphine

12. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=54
    January 01, 2024 - Systems, Medicaid, Healthcare Delivery Jakubowski A , Norton BL , Hayes BT Low-threshold buprenorphine … They found that, in an SSP-based low-threshold buprenorphine treatment program, approximately one-third … of patients continued buprenorphine treatment for 180 days or more, and buprenorphine adherence was … They concluded that SSPs can be a pathway to buprenorphine treatment for patients at high risk for opioid-related … Low-threshold buprenorphine treatment in a syringe services program: program description and outcomes

13. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=238
    January 01, 2024 - Practice Patterns Samples H , Williams AR , Olfson M Risk factors for discontinuation of buprenorphine … The purpose of this study was to examine duration of buprenorphine treatment for opioid use disorder … ; their sample included adults aged 18-64 years who had an OUD diagnosis 6 months before initiating buprenorphine … More than 1/4 of the sample discontinued buprenorphine in the first month of treatment, and most of the … Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state

14. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=448
    January 01, 2024 - Determinants of Health, Obesity Turner L , Kruszewski SP , Alexander GC Trends in the use of buprenorphine … This study used descriptive statistics to examine trends in buprenorphine utilization from 2003 to 2013 … The use of buprenorphine products to treat opioid dependence has increased significantly and has shifted … Trends in the use of buprenorphine by office-based physicians in the United States, 2003-2013.

15. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=407
    January 01, 2024 - Elderly, Injuries and Wounds Kao DP , Haigney MC , Mehler PS Arrhythmia associated with buprenorphine … corrected QT interval prolongation or torsade de pointes to the US Food and Drug Administration between buprenorphine … countries, methadone is associated with disproportionate reporting of cardiac arrhythmias, whereas buprenorphine … Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration.

16. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=98
    January 01, 2024 - Quality, Patient Safety, Quality Improvement, Quality of Care Lillie KM , Shaw J , Jansen KJ Buprenorphine … The objective of this study was to identify variables associated with buprenorphine/naloxone retention … younger patients and those with co-occurring substance use remained at higher risk of discontinuing buprenorphine … Buprenorphine/naloxone for opioid use disorder among Alaska Native and American Indian people.

17. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=57
    January 01, 2024 - MK , Drake C , Saloner B Medicaid managed care: access to primary care providers who prescribe buprenorphine … This study examined variation in access to in-network buprenorphine-prescribing primary care providers … Approximately 32.2% of Medicaid enrollees had fewer than one in-network network buprenorphine-prescribing … There was on average a greater number of in-network buprenorphine-prescribing primary care providers … Medicaid managed care: access to primary care providers who prescribe buprenorphine.

18. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=85
    January 01, 2024 - Sussman AL , Crawford JN , Brakey HR Use of a benchmark tracking assessment to support expansion of buprenorphine … Barriers to the expansion of opioid use disorder (OUD) treatment in primary care using buprenorphine … study to examine the impact of provider participation in an online intervention to support expansion of buprenorphine … Use of a benchmark tracking assessment to support expansion of buprenorphine for treatment of opioid

19. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=169
    January 01, 2024 - Author: H Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine … Although buprenorphine treatment reduces risk of overdose and death in opioid use disorder, most patients … In this study, adverse health outcomes following buprenorphine discontinuation were compared among patients … Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine

20. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=82
    January 01, 2024 - Wyse JJ , Morasco BJ , Dougherty J Adjunct interventions to standard medical management of buprenorphine … adjunctive interventions supportive of engagement and retention in treatment among patients receiving buprenorphine … effect on key outcomes of adjunctive interventions provided alongside standard medical management of buprenorphine … Adjunct interventions to standard medical management of buprenorphine in outpatient settings: a systematic